Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Aerial shot of neighborhood | Image credit: trekandphoto – stock.adobe.com

How Neighborhood Social Needs Drive Diabetes Care Disparities

By Hayden E. Klein

October 18th 2024

Unmet social needs in certain neighborhoods contribute to disparities in diabetes care, leading to greater reliance on emergency services, fewer preventive measures, and higher rates of complications.

Lifestyle and dietary changes have proven benefits for patients with diabetes, sometimes eliminating the need for their medications | image credit: Africa Studio - stock.adobe.com

The Off-Ramp: Novel Diabetes Reversal Program Bolsters Support of Nonpharmacological Disease Management

October 8th 2024

Diabetes | Image credit: Sherry Young – stock.adobe.com

What the Diabetes Health Economy Looks Like in 2024

By Hayden E. Klein

October 1st 2024

Senate. | Image Credit: Corgarashu - stock.adobe.com

Semaglutide Accessibility and Affordability Addressed at Senate Committee Hearing

By Cameron Santoro

September 24th 2024

Gavel and money | Image credit: BillionPhotos.com - stock.adobe.com

FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs

By Skylar Jeremias

September 20th 2024

More News

September 29th 2015

Lixisenatide New Drug Application Accepted for Review With CV Results Already in Hand

Mary K. Caffrey

Results presented at the American Diabetes Association in June showed no CV risk or benefit and no risk of pancreatic injury, an issue that has been of particular concern to FDA.

September 28th 2015

Behavioral Health at Heart of Recommended Medicaid Measures From National Quality Forum

Mary K. Caffrey

The recommendations for improving quality care in Medicaid track recent trends in psychiatric and diabetes care, which recognize the connection between physical and mental health.

September 28th 2015

Medtronic Announces US Availability of MiniMed Connect Technology

Mary K. Caffrey

The technology was approved by FDA in June and unveiled at the Scientific Sessions of the American Diabetes Association.

September 28th 2015

Diabetes: The Next Healthcare Tsunami

Eighty-six million US adults are at high risk of developing type 2 diabetes. Without prevention, there will be a drastic increase in the number of Americans who will develop type 2 diabetes.

September 25th 2015

Dexcom G5 Mobile CGM System Approved by FDA

Mary K. Caffrey

September 25th 2015

Synjardy Joins Ranks of Combo Therapies for T2DM

Mary K. Caffrey

September 25th 2015

Outlook Changing in Payer Coverage for Obesity Medications, Commentators Say

Many hoped the 2013 declaration by the American Medical Association that obesity is a disease would open the door for payer coverage of pharmacotherapy to treat it. While that did not happen right way, a new commentary in Evidence-Based Diabetes Management by Ted Kyle, RPh, MBA, and Fatima Cody Stanford, MD, MPH, MPA, outlines how the tide appears to be turning for coverage of evidence-based treatment.

September 25th 2015

Joslin Diabetes Center Taps Amenta as New President & CEO

Mary K. Caffrey

Peter S. Amenta, MD, PhD, spent 8 years as the dean of Rutgers Robert Wood Johnson Medical School during a period of tremendous growth and change.

September 24th 2015

Empagliflozin Is First Diabetes Drug to Hit "Holy Grail" of Cutting Heart Attack, Stroke Deaths in Clinical Trial

Mary K. Caffrey

September 24th 2015

Blood Pressure Medication at Night Lowers Diabetes Risk, Studies Say

Mary K. Caffrey

The research by the group from Spain is the latest effort to link sleep patterns, or disruption of sleep, to the development of type 2 diabetes.

September 23rd 2015

Fingernail Tests May Offer Cheap, Simple Way to Diagnose Diabetes

Mary K. Caffrey

Fingernail tests could offer a solution to diabetes testing in the developing world, and a faster test for gestational diabetes could diagnose this condition earlier in pregnancy.

September 23rd 2015

Dissecting the Patient Perception of FDA's Breakthrough Designation

Surabhi Dangi-Garimella, PhD

A JAMA Internal Medicine study found the terms "breakthrough" and "promising" raised people's expectations on the drug's performance as opposed to when the drugs were described as having met the breakthrough criteria.

September 23rd 2015

Survey Finds Young Patients With Diabetes Getting Fewer Eye Exams Than Older Patients

Mary K. Caffrey

Younger patients and those newly diagnosed were more likely to not receive eye exams than older persons with diabetes.

September 23rd 2015

Type 2 Diabetes Patients Should Be Screened for Liver Disease, Study Suggests

Mary K. Caffrey

Screening in a primary care setting may help managed care plans avoid long-term costs of complications of type 2 diabetes.

September 23rd 2015

Clinton Seeks Cap on Drug Expenses, Would Let Medicare Negotiate

Mary K. Caffrey

Hillary Clinton unveiled a plan in Iowa that features a $250 per month cap on drug costs for patients with chronic conditions. This comes 2 weeks after her chief rival for the Democratic nomination, US Senator Bernie Sanders of Vermont, introduced a bill aimed at reining in drug costs. In the summer, The American Journal of Managed Care said polling showed that rising drug costs were poised to become a major issue in the 2016 campaign.

September 23rd 2015

Physicians Believe in Biosimilars but Lack Awareness, Says Report by Quantia

Surabhi Dangi-Garimella, PhD

A white paper released by QuantiaMD has identified a lack of awareness and education about biosimilars among prescribing physicians.

September 22nd 2015

Intarcia Says Phase 3 Results Show Better Control Than Januvia for Type 2 Diabetes Mellitus

Mary K. Caffrey

The matchstick-like delivery system has been seen as game-changer in overcoming poor adherence. Filing for FDA approval is anticipated in early 2016.

September 22nd 2015

JAMA: High-Dose Liraglutide Causes Significant Weight Loss in Overweight Persons With T2DM

Mary K. Caffrey

The study showed an average weight loss of 6%, and weight loss of 10% for a quarter of the patients. Average BMI was 37.

September 22nd 2015

Research Describes "Dimmer Switch" in Pancreatic Islet Cells

The research could hold the key to a novel treatment for type 2 diabetes, although it will take years to adapt the idea to clinical practice.

September 21st 2015

Does Passive Smoking Boost Diabetes Risk? A Lancet Meta-analysis Says Yes

Mary K. Caffrey

Researcher found that not only was passive smoking associated with increased risk of type 2 diabete, but there was a direct dose-response relationship.

September 21st 2015

New FDA Nominee May Face Challenges for His Pharma Ties

Surabhi Dangi-Garimella, PhD

A report in The New York Times identifies challenges that could be raised based on Califf's past associations with the drug industry.

Dr Andrew Pumerantz Reflects on the Role of Primary Care in Diabetes

September 21st 2015

Dr Andrew Pumerantz Reflects on the Role of Primary Care in Diabetes

Although primary care is important, it may not be the center of the care model for patients with chronic diseases, like type 2 diabetes, and these providers are usually just a part of a larger ecosystem of providers, said Andrew Pumerantz, DO, FACP.

September 19th 2015

Integrating Community, Clinical Services to Prevent and Treat Obesity

Laura Joszt, MA

Researchers are proposing a new model to integrate clinical and community services for the purpose of preventing and controlling obesity, as well as related chronic diseases, such as type 2 diabetes.

September 18th 2015

Stumbling Toward Access to Evidence-Based Care for the Chronic Disease of Obesity

Theodore K. Kyle, RPh, MBA: Fatima Cody Stanford, MD, MPH, MPA

Many hoped the 2013 declaration by the American Medical Association that obesity is a disease would open the door to improved coverage for pharmcotherapy. That did not happen right away, but signs of change are emerging.

September 18th 2015

Joslin's Hamdy: Evidence Shows Diet, Exercise Effective Against Diabetes, Obesity Long-Term

A 5-year study reveals that the properly constructed diet, along with exercise aimed at muscle maintenance, can achieve long-term weight loss results.

September 18th 2015

"Artificial Pancreas" System Performs Well in Home-Based Trial, Researchers Report

Mary K. Caffrey

Patients whose blood sugar and insulin delivery was managed by software had been control than those who had to self-monitor their insulin delivery.

September 18th 2015

NIH Approves Blueprint for Obama's Precision Medicine Initiative

Surabhi Dangi-Garimella, PhD

The path to President Obama's Precision Medicine Initiative has been paved as is evident from a report released by a Working Group convened by the National Institutes of Health.

September 18th 2015

Explaining a Mystery of Insulin-Producing Cells to Find Treatments for Type 2 Diabetes

Work at the Karolinska Institutet has revealed a potential new therapeutic target in type 2 diabetes.

September 17th 2015

Lancet Study Evaluates Cost-Effectiveness of Bariatric Surgery

Mary K. Caffrey

The long-term claimed to be the first to use real world data to capture the complete picture of the value of paying for bariatric surgery in patients with diabetes.

September 17th 2015

Empagliflozin Shown to Cut Mortality Risk in Long-Term CV Outcomes Trial

Mary K. Caffrey

Presentation of results at the European Association for the Study of Diabetes follows the announcement of topline results in August. For years, researchers and pharmaceutical leaders alike wondered if a diabetes therapy would be shown to have a cardioprotective effect.

...

67 68 69 70 71 72 73 74 75

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions